Sunitinib Malate로 치료한 악성 과립상 세포종 1예
- Alternative Title
- Patient with Malignant Granular Cell Tumor Treated with Sunitinib Malate
- Abstract
- Malignant granular cell tumors (MGST) are extremely rare, high-grade sarcoma of schwann cell origin. They often metastasize and are associated with short survival. We described a patient with recurred MGST after wide marginal excision followed by chemotherapy. The histologic findings revealed relapsed MGST containing rich vascular structure. The patient was treated with sunitinib malate (50 mg/day) for three weeks. Because sunitinib malate has a potent antiangiogenic property, we surmised that it might be effective against this type of malignancy. However, he died due to progression of tumor after six weeks. Here, we report it along with the corresponding literature.
- All Author(s)
- S. J. Lee
; J. H. Kim
; H. W. Cho
; G. J. Na
; H. J. Kim
; S. B. Bae
; K. T. Lee
- Issued Date
- 2012
- Type
- Article
- Keyword
- Malignant; Granular cell tumor; Sunitinib
- Publisher
- Soonchunhyang Medical Research Institute
- ISSN
- 2233-4289
; 2233-4297
- Citation Title
- Soonchunhyang Medical Science
- Citation Volume
- 18
- Citation Number
- 1
- Citation Start Page
- 66
- Citation End Page
- 69
- Language(ISO)
- kor
- DOI
- 10.15746/sms.12.013
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/2208
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.